We are live on
!
Find out more
DY
Dowling & Yahnke Portfolio holdings
AUM
$2.15B
Turnover
6.98%
1-Year Est. Return
10.82%
This Fund
S&P 500
This Quarter
Est. Return
+3.88%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$774M
AUM Growth
+$15.3M
(+2%)
Cap. Flow
-$9.61M
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
26.39%
Holding
284
New
7
Increased
63
Reduced
151
Closed
12
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Interactive Brokers
IBKR
|
+$920K |
| 2 |
Apple
AAPL
|
+$848K |
| 3 |
Caterpillar
CAT
|
+$737K |
| 4 |
Vanguard Materials ETF
VAW
|
+$304K |
| 5 |
IBM
IBM
|
+$298K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$978K |
| 2 |
Reliance Steel & Aluminium
RS
|
+$643K |
| 3 |
Neurocrine Biosciences
NBIX
|
+$483K |
| 4 |
ACO
AMCOL International Corp
ACO
|
+$483K |
| 5 |
Johnson & Johnson
JNJ
|
+$450K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.26% |
| 2 | Healthcare | 13.17% |
| 3 | Consumer Staples | 12.92% |
| 4 | Technology | 11.77% |
| 5 | Financials | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
National Fuel Gas
NFG
$7.45B
| $222K | 0.03% |
2,840
-160
| -5% | -$11.8K |
2014 Q1
1 quarter
|
|
252
Ambarella
AMBA
$2.8B
| $221K | 0.03% |
7,100
-400
| -5% | -$10.6K |
2013 Q4
2 quarters
|
|
253
Western Alliance Bancorporation
WAL
$8.11B
| $220K | 0.03% |
9,246
| – | – |
2013 Q4
2 quarters
|
|
254
Murphy Oil
MUR
$5.71B
| $216K | 0.03% |
3,245
| – | – |
2013 Q4
2 quarters
|
|
|
AGN
255
DELISTED
Allergan plc
AGN
| $212K | 0.03% |
+949
| New | +$196K |
2014 Q2
0 quarters
|
|
256
Insight Enterprises
NSIT
$4.66B
| $209K | 0.03% |
+6,784
| New | +$188K |
2014 Q2
0 quarters
|
|
257
Enterprise Products Partners
EPD
$76.8B
| $207K | 0.03% |
+5,290
| New | +$195K |
2014 Q2
0 quarters
|
|
258
DELISTED
Time Inc.
TIME
| $203K | 0.03% |
+8,389
| New | +$196K |
2014 Q2
0 quarters
|
|
259
DNOW Inc
DNOW
$2.72B
| $202K | 0.03% |
+5,566
| New | +$192K |
2014 Q2
0 quarters
|
|
260
Insulet
PODD
$9.62B
| $201K | 0.03% |
5,075
| – | – |
2014 Q1
1 quarter
|
|
261
Tandem Diabetes Care
TNDM
$1.15B
| $165K | 0.02% |
+1,014
| New | +$173K |
2014 Q2
0 quarters
|
|
|
DYSL
262
DELISTED
Dynasil Corporation of America
DYSL
| $136K | 0.02% |
77,432
+6,421
| +9% | +$10.2K |
2013 Q2
4 quarters
|
|
|
RJI
263
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Total Return
RJI
| $134K | 0.02% |
15,545
| – | – |
2014 Q1
1 quarter
|
|
|
LQMT
264
DELISTED
LIQUIDMETAL TECHNOLOGIES INC
LQMT
| $55K | 0.01% |
214,500
| – | – |
2013 Q2
4 quarters
|
|
265
BP
BP
$125B
| – | – |
-5,350
| Closed | -$210K | – |
|
266
DELISTED
Calavo Growers
CVGW
| – | – |
-5,910
| Closed | -$210K | – |
|
|
267
Neurocrine Biosciences
NBIX
$13.9B
| – | – |
-30,000
| Closed | -$483K | – |
|
268
Vodafone
VOD
$36.7B
| – | – |
-9,668
| Closed | -$356K | – |
|
|
BBBY
269
DELISTED
Bed Bath & Beyond Inc
BBBY
| – | – |
-5,305
| Closed | -$365K | – |
|
|
ALBO
270
DELISTED
Albireo Pharma Inc
ALBO
| – | – |
-2,135
| Closed | -$175K | – |
|
|
CPN
271
DELISTED
Calpine Corporation
CPN
| – | – |
-10,000
| Closed | -$209K | – |
|
|
ACO
272
DELISTED
AMCOL International Corp
ACO
| – | – |
-10,540
| Closed | -$483K | – |
|
Similar funds
AC
APA
IC
SCA
ACM
W
Dowling & Yahnke's Q2 2014 Portfolio in Review
As of Q2 2014, Dowling & Yahnke held 284 positions worth $774M, up 2% from $759M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Dowling & Yahnke's Q2 2014 filing shows 7 new, 63 increased, 151 reduced and 12 closed positions. Its largest new stake was Allergan plc: 949 shares worth $212K. The largest sale was Coca-Cola, an estimated $978K.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.
- Dowling & Yahnke's largest Q2 2014 buy was Allergan plc: 949 shares worth $212K.
- Dowling & Yahnke added most to Interactive Brokers in Q2 2014, an estimated $920K increase.
- Dowling & Yahnke's biggest Q2 2014 reduction was Coca-Cola, cutting an estimated $978K.
- Dowling & Yahnke fully exited AMCOL International Corp in Q2 2014, selling an estimated $483K.
- Dowling & Yahnke's ten largest holdings make up 26% of its $774M portfolio in Q2 2014.
- Dowling & Yahnke opened 7 new positions and closed 12 in Q2 2014.
- Dowling & Yahnke's portfolio value rose 2% quarter-over-quarter to $774M.
Based on Dowling & Yahnke's 13F filing for Q2 2014, filed 15 Aug 2014.